Additively manufactured medical products – the FDA perspective

Journal Title: 3D Printing in Medicine - Year 2016, Vol 2, Issue

Abstract

Additive manufacturing/3D printing of medical devices is becoming more commonplace, a 3D printed drug is now commercially available, and bioprinting is poised to transition from laboratory to market. Despite the variety of technologies enabling these products, the US Food and Drug Administration (FDA) is charged with protecting and promoting the public health by ensuring these products are safe and effective. To that end, we are presenting the FDA’s current perspective on additive manufacturing/3D printing of medical products ranging from those regulated by the Center for Devices and Radiological Health (CDRH), the Center for Drug Evaluation and Research (CDER), and the Center for Biologics Evaluation and Research (CBER). Each Center presents an overview of the additively manufactured products in their area and the specific concerns and thoughts on using this technology in those product spaces.

Authors and Affiliations

Matthew Di Prima, James Coburn, David Hwang, Jennifer Kelly, Akm Khairuzzaman, Laura Ricles

Keywords

Related Articles

Additively manufactured medical products – the FDA perspective

Additive manufacturing/3D printing of medical devices is becoming more commonplace, a 3D printed drug is now commercially available, and bioprinting is poised to transition from laboratory to market. Despite the variety...

A rapid and intelligent designing technique for patient-specific and 3D-printed orthopedic cast

Two point four out of 100 people suffer from one or more fractures in the course of average lifetimes. Traditional casts are featured as cumbersome structures that result in high risk of cutaneous complications. Clinical...

Rapid customization system for 3D-printed splint using programmable modeling technique – a practical approach

Clinicians, medical engineers, and designers are welcome to contact the corresponding author to obtain the program.

Identifying a commercially-available 3D printing process that minimizes model distortion after annealing and autoclaving and the effect of steam sterilization on mechanical strength

Fused deposition modeling 3D printing is used in medicine for diverse purposes such as creating patient-specific anatomical models and surgical instruments. For use in the sterile surgical field, it is necessary to under...

Download PDF file
  • EP ID EP680667
  • DOI  10.1186/s41205-016-0005-9
  • Views 47
  • Downloads 0

How To Cite

Matthew Di Prima, James Coburn, David Hwang, Jennifer Kelly, Akm Khairuzzaman, Laura Ricles (2016). Additively manufactured medical products – the FDA perspective. 3D Printing in Medicine, 2(), -. https://europub.co.uk/articles/-A-680667